Primary/Neoadjuvant Chemotherapy for Early Breast Cancer
Ian E. Smith M.D., F.R.C.P., F.R.C.P.E.,
Corresponding Author
Ian E. Smith M.D., F.R.C.P., F.R.C.P.E.
Royal Marsden Hospital, Breast Unit, London and Surrey, U.K.
Address correspondence and reprint requests to: Dr. Ian E. Smith, M.D., Royal Marsden Hospital, Fulham Road, London SW3Search for more papers by this authorIan E. Smith M.D., F.R.C.P., F.R.C.P.E.,
Corresponding Author
Ian E. Smith M.D., F.R.C.P., F.R.C.P.E.
Royal Marsden Hospital, Breast Unit, London and Surrey, U.K.
Address correspondence and reprint requests to: Dr. Ian E. Smith, M.D., Royal Marsden Hospital, Fulham Road, London SW3Search for more papers by this author
REFERENCES
- 1 Haagensen CD, Bodian C. A personal experience with Halsted's radical mastectomy. Ann Surg 1984; 199: 143–50.
- 2 Anderson ED, Forrest AP, Hawkins RA, et al. Primary systemic therapy for operable breast cancer. Br J Cancer 1991; 63: 561–66.
- 3 Bonadonna G, Valagussa P, Zucali R, Salvadori B. Primary chemotherapy in surgically resectable breast cancer. CA Cancer J Clin 1995; 45: 227–43.
- 4
Jacquillat C,
Weil M,
Baillet F, et al.
Results of neo-adjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer.
Cancer
1990; 66: 119–29.
10.1002/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3 PubMed Web of Science® Google Scholar
- 5 Chollet P, Belembaogo E, Cure H, et al. Four year results of neoadjuvant chemotherapy for 148 operable breast cancers. Proc Annu Meet Am Soc Clin Oncol 1993; 12(Abstract): A157.
- 6 Mansi J, Smith IE, Walsh G, et al. Primary medical therapy for operable breast cancer. Eur J Cancer Clin Oncol 1989;Vol. 25, 11:1623–27.
- 7 Smith IE, Walsh G, Jones A, et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 1995; 13: 424–29.
- 8 Jones AL, Smith IE, O'Brien MER, et al. Phase II study of continuous infusional 5FU with epirubicin and cisplatin (infusional ECF) in patients with metastatic and locally advanced breast cancer: an active new regimen. J Clin Oncol 1994; 12: 1259–65.
- 9 Fisher B, Rockette H, Robidoux A, et al. Effect of preoperative therapy for breast cancer in loco-regional disease. First report of NSABP B-18. Proc Am Soc Clin Oncol 1994; 13(Abstract): 64.
- 10 Powles TJ, Hickish TF, Makris A, et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995; 13: 547–52.
- 11 Mauriac L, Durand M, Avril A, Dilhuydy J-M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumours larger than 3 cm. Ann Oncol 1991; 2: 347–54.
- 12 Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors too large for breast conserving surgery: preliminary results of a randomized trial. Eur J Cancer 1994; 30A: 645–52.
- 13 Semiglazov VF, Topuzov EE, Bavli JL, et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994; 5/7: 591–95.
- 14 Danforth D, Jacobson J, O'Shaughnessy J, et al. Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: a prospective randomized trial. Proc Annu Meet Am Soc Clin Oncol 1995; 14(Abstract): A213.
- 15 Scholl SM, Pierga JY, Asselain B, et al. Breast tumour response predicts local and distant control as well as survival. Eur J Cancer 1995; 12: 1969–75.
- 16 Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognostic value of lymph node metastases after neo-adjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg 1995; 181/3: 202–8.
- 17 Ellis PA, Smith IE, Salter J, et al. Pre-operative/neoadjuvant chemotherapy for early breast cancer induces apoptosis. Proc Am Soc Clin Oncol 1996; 15(Abstract): 112.
